6 Einträge gefunden

1. Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancer

   1. Möller, Katharina
   2. Kluth, Martina
   3. Ahmed, Malik
   4. Burkhardt, Lia
   5. Möller-Koop, Christina
   6. Büscheck, Franziska
   7. Weidemann, Sören

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer

   1. Freytag, Morton
   2. Kluth, Martina
   3. Bady, Elena
   4. Hube-Magg, Claudia
   5. Makrypidi-Fraune, Georgia
   6. Heinzer, Hans
   7. Höflmayer, Doris

   2020 - Forschungsinformationssystem des UKE
3. Deletion of 18q is a strong and independent prognostic feature in prostate cancer

   1. Kluth, Martina
   2. Graunke, Maximilian
   3. Koop, Christina
   4. Hube-Magg, Claudia
   5. Minner, Sarah
   6. Michl, Uwe
   7. Graefen, Markus

   2016 - Forschungsinformationssystem des UKE
4. Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

   1. Burdelski, Christoph
   2. Reiswich, V.
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2015 - Forschungsinformationssystem des UKE
5. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion

   1. Tsourlakis, Maria C
   2. Weigand, Philipp
   3. Grupp, Katharina
   4. Kluth, Martina
   5. Steurer, Stefan
   6. Schlomm, Thorsten
   7. Graefen, Markus

   2014 - Forschungsinformationssystem des UKE
6. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer

   1. Burkhardt, Lia
   2. Fuchs, Sarah
   3. Krohn, Antje
   4. Masser, Sawinee
   5. Mader, Malte
   6. Kluth, Martina
   7. Bachmann, Frederik

   2013 - Forschungsinformationssystem des UKE